Publicacions

  • Ali HS. Patient-centered pharmacovigilance: a review. Trop J Pharm Res 2018;17:179-188.  Enllaç
  • Rodrigues-Neto AJ. Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes. Eur J Clin Pharmacol 2018;:1-4.  Enllaç
  • Ribeiro A. Filling quality of the reports of adverse drug reactions received at the pharmacovigilance centre of Sâo Paulo (Brazil): missing information hinders the analysis of suspected associations. Expert Opinion on Drug Safety 2017;16:1329-1334.  Enllaç
  • Corrêa de Matos G. The inconveniences of polysemy in the database era - don't call it "drug" unless you mean it. Pharmacoepidemiology and Drug Safety 2015;24:673-675.  Enllaç
  • Habarugira JMV. Serious adverse events reporting and follow-up requeriments in the European and Developing Countries Clinical Trials Partnership-funded clinical trials: current practice. J Pharmacovigil 2014;2:148.  Enllaç
  • Rico-Alba I. The evolution of reference drug lists and clinical practice guidelines in the public health system of a middle-income country. Br J Clin Pharmacol 2014;78:410-421.
  • Rico-Alba I. The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis. Eur J Clin Pharmacol 2013;69:949-956.  Enllaç
  • Vaca González CP. Algorithm for the evaluation of therapeutic failure reports - Proposal and pilot analysis. Pharmacoepidemiology and Drug Safety 2013;22:199-206.  Enllaç
  • Milone MC. Sobreutilización de inhibidores de la acidez gástrica en pacientes pediátricos. Overuse of acid-suppresive therapy in pediatric patients. Revista de Salud Pública 2012;16:27-35.
  • Barbosa R. Prevalence of potential drug-drug interactions in bone marrow transplant patients. Int J Clin Pharmacy 2011;33:1002-1009.  Enllaç
  • Moyano JR. The Medical Consumption of Opioids in Colombia, 1997-2007. Journal of Pain & Palliative Care Pharmacotherapy 2010;24:367-373.  Enllaç
  • Moreira AM. Analysis of the evidence of efficacy and safety of over-the-counter cough medications registered in Brazil. Braz J Pharm Sci 2010;46:135-145.  Enllaç
  • Ruiz F. Self-medication in older urban Mexicans. An observational, descriptive, cross-sectional study. Drugs Aging 2009;26:51-60.
  • Reis A. Evidences of efficacy and safety of over-the-counter medications for cough registered in Brazil: a challenge to pharmacovigilance. Drug Safety 2008;31:885.  Enllaç
  • Figueras A. An education and motivation intervention to change clinical management of the third stage of labor - the GIRMMAHP initiative. BIRTH 2008;35:283-290.  Enllaç
  • Valsecia M. Sobre la necesaria aplicación del razonamiento en procesos de prescripción. Rev Port Clin Geral 2008;24:619-623.
  • Mino-León D. Drug treatment of hypertension: compliance and adverse reactions in a cohort of hypertensive patients in a primary care setting. Revista de Investigación Clínica 2007;59:8-14.  Enllaç
  • Castel JM. The internet as a tool in clinical pharmacology. Br J Clin Pharmacol 2006;61:787-790.  Enllaç
  • Maldonado JC. Long-term effects of an educational intervention on self-medication and appropriate drug use in single-sex secondary public schools, Quito, Ecuador. Br J Clin Pharmacol 2006;63:92-99.  Enllaç
  • Figueras A. Consumption costs of inappropriate medicines estimated from bulk purchase data: the example of NSAIDs in Guatemala. Int J Clin Pharmacol Ther 2006;44:566-571.
  • Figueras A. Getting knowledge into clinical practice. Br Med J 2006;333:1221.  Enllaç
  • Vacca C. Assessment of risks related to medicine dispensing by nonprofessionals in Colombia: clinical case simulations. Ann Pharmacother 2005;39:527-532.
  • Napchan BM. From suspicion to action: the chemical conjunctivitis and silver nitrate connexion example in Brazilian hospitals. Pharmacoepidemiol Drug Safety 2005;14:555-559.
  • Passarelli MC. Adverse drug reactions in an elderly hospitalised population. Inappropriate prescription is a leading cause. Drugs Aging 2005;22:767-777.
  • Hutangkabodee S. Regulatory evaluation of efficacy and safety of new drugs in Thailand. J Med Assoc Thai 2004;87:1135-1136.
  • Figueras A. Securing reproductive rights. Lancet 2004;363:989.  Enllaç
  • Figueras A. Medicaments I globalització. L'ús racional contra l'abús de les marques. Vall d'Hebron Hospital 2003;32:18-19.
  • Diogène E. The Cuban experience in focusing pharmaceuticals policy to health population needs: initial results of the National Pharmacoepidemiology Network (1996-2001). Pharmacoepidemiol Drug Safety 2003;12:405-407.  Enllaç
  • Reggi V. Regulatory assessment of new drugs in developing countries. Lancet 2003;362:249-250.  Enllaç
  • Sanae C. Estudo de utilizaçâo de cefalosporinas em pacientes hospitalizados: resultados do programa de farmacoviglilância hospitalar, CVS-SP. Revista do Farmacêutico 2003;maio:19.
  • Sanae C. Prescriçâo de medicamentos para idosos hospitalizados: resultados do programa de farmacovigilância hospitalar, CVS-SP. Revista do Farmacêutico 2003;maio:31.
  • Pérez Peña J. Una politica di farmaci basata sulle necessità e sulle richieste: la ricerca nella rete cubana di farmacoepidemiologia. Ricerca & Practica 2003;19:96-102.
  • Figueras A. Regulatory decisions in a globalised world. The domino effect of phenylpropanolamine withdrawal in Latin America. Drug Safety 2002;25:689-693.  Enllaç
  • Figueras A. Health needs, drug registration and control in less developed countries - the Peruvian case. Pharmacoepidemiol Drug Safety 2002;11:63-64.  Enllaç
  • Figueras A. Therapeutic consultation centres are helpful in developing countries. Br Med J 2002;324:236.  Enllaç
  • Figueras A. Therapeutic ineffectiveness. Heads or tails?. Drug Safety 2002;25:485-487.  Enllaç
  • Debesa F. Spontaneous reporting of adverse drug reactions in Cuba: integrating continuous education, training and research in a network approach. Br J Clin Pharmacol 2002;54:335-336.  Enllaç
  • Valsecia ME. Interaction between orlistat and antihypertensive drugs. Ann Pharmacother 2001;35:1495-1496.
  • Diogène E. Cuba: a national drug policy oriented to health population needs. In: Velo G, Perucca E (eds), VII World Conference on Clinical Pharmacology and Therapeutics & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), abstract nº 20. Br J Clin Pharmac 2000;49:6.
  • Figueras A. New drugs, new adverse drug reactions, and bibliographic databases. Lancet 1999;353:1447-1448.  Enllaç
  • Heineck I. Medicamentos de venta libre en el Brasil. Rev Panam Salud Pública/Pan Am J Public Health 1998;6:385-391.  Enllaç
  • Drug Utilization Research Group. Multicenter study on self-medication and self-prescription in six Latin American countries. Clin Pharmacol Ther 1997;61:488-493.
  • Laporte JR. Cuba: improving use of medicines. Lancet 1997;349:4.
  • Laporte JR. Towards a healthy use of pharmaceuticals. Development Dialogue 1985;2:48-55.  Enllaç
  • Laporte JR. Drug policy in Nicaragua: between need-oriented activities and aggression. Development Dialogue 1985;2:121-128.  Enllaç